We’re seeing this type of activity pick up in Snap Inc (SNAP) as price – in a downtrend – made yet another new low.
SNAP is a great example of our “weak stocks getting weaker” principle which has us trading retracements IN the direction of the prevailing trend and NOT against it.activity downtrend falling Motion pick SNAP trade traders Trend type
CVS (CVS) has been a bit of a disappointment for shareholders in the past couple of years. An upbeat Q2 report had the stock perking up and some important technical hurdles have been crossed, so is this the time where you can actually buy CVS?bullish CVS growth higher margin mentioned rally Revenue stock upside
As the Trump administration looks to take a tougher stance against Beijing, Chinese investments in the U.S. have more than halved this year, according to Dealogic.
To be sure, other lawyers and analysts said Chinese investment in U.S. real estate and industries outside of sensitive areas such as technology may not be as affected by the Trump administration.administration analysts Beijing Chinese Dealogic firm investment side Trump uncertainty
AbbVie is on track to submit an NDA for elagolix in endometriosis before the end of Q3. The company has made considerable progress on all fronts over the last few months - Ingrezza is off to a strong start, partner AbbVie (NYSE:ABBV) is on track to submit an NDA for elagolix in endometriosis this quarter and to report phase 3 data in uterine fibroids in late 2017 or early 2018 while Asia partner Mitsubishi Tanabe (OTCPK:MTZPY) intends to start a Phase 3 trial of Ingrezza in Japan.AbbVie early elagolix Ingrezza Neurocrine Phase quarter results sales study
Facebook is a technology on the forefront of innovation in social media, with strong and increasing network effects. Facebook’s corporate strategy has significant barriers to entry signified by the fact that no other social media company comes close to the user base, nor the depth to which its users interact with its multi-faceted interface.earnings Facebook FB growing growth multiple rate Revenue strong user
Pepsi CEO Indra Nooyi, one of the most powerful women and minorities in business, is being aggressively pressured by a racial justice group to quit President Trump's advisory council.
Color of Change, a racial justice organization, is urging its 1 million members to hold Pepsi (PEP) and its huge array of products "accountable" if Nooyi doesn't step down from Trump's manufacturing council.business CEO CHARLOTTESVILLE color Council Nooyi Pepsi powerful Trump violence
Depending on the penetration rate, we believe this deal is worth somewhere between $10 and $180 million over the life of the deal. So, depending on the ultimate penetration rate, the company's expectations imply that this deal is worth somewhere between $10 and $180 million over the life of the deal.American blind investment market smart glasses ve VUZI Vuzix Wounded Warrior year
Recently, a real-time follower here on Seeking Alpha asked me to research and post my thoughts around a small, early stage gene therapy concern. Recently, coverage was resumed at Stifel with a $20 price target based on “great promise” showed by the company’s lead drug candidate in Parkinson’s.candidate disease lead patient quarter Recently stage time VY years
The retail industry has been in turmoil this year, and as more companies are reporting, it doesn’t seem to be getting any better. Most expected this struggling retailer to tank on this earnings report, but it surprised analysts and investors, bouncing off a multiyear low.comparable EPS net Outfitters rating raised Retail Revenue sales segment Urban